JoelDavidBigleyMD

Urology • Pittsburgh, PA

Stone Disease

Assistant VP, Surgery and Section Chief, Urology, VA Pittsburgh Healthcare System Assistant Professor, UPMC Shadyside

Join to view full profile

Dr. Bigley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bigley's full profile

Already have an account?

Office
5230 Centre Avenue
Medical Arts Building, Suite 209
Pittsburgh, PA 15232
Phone+1 412-605-3041

Fax+1 412-605-3030

Education & Training

UPMC Medical EducationResidency, Urology, 2009 - 2013
West Virginia University School of MedicineClass of 2007

Certifications & Licensure

PA State Medical License 2007 - 2022
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

7 citations
Efficacy of single-source rapid kV-switching dual-energy CT for characterization of non-uric acid renal stones: a prospective ex vivo study using anthropomorphic phantom
Roberto Cannella, Mohammed Shahait, Alessandro Furlan, Feng Zhang, Joel Bigley
Abdominal Radiology. 2020-04-01
22 citations
E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer
Feng Li, Laura E. Pascal, Donna B. Stolz, Ke Wang, Yibin Zhou
The Prostate. 2019-08-01
E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
Feng Li, Laura E Pascal, Donna B Stolz, Ke Wang, Yibin Zhou
The Prostate. 2019-06-19